CD38 and B-cell chronic lymphocytic leukemia: The critical roles for MSI2 in CLL-cell survival and growth likely relate to the higher MSI2 levels in CLL cells expressing poor outcome prognostic markers, i.e., unmutated IGHV and elevated numbers of CD38+ cells [27, 31, 32], and experiencing shorter TTFT and OS.